A1C 13.3% — what it means
An HbA1c of 13.3% corresponds to an estimated average glucose of 335 mg/dL (18.6 mmol/L) and an IFCC value of 122 mmol/mol. Diabetes range
Result summary for an A1C of 13.3%
| Measure | Value |
|---|---|
| NGSP / DCCT A1C | 13.3% |
| IFCC A1C | 122 mmol/mol |
| Estimated average glucose (eAG) | 335 mg/dL |
| eAG in mmol/L | 18.6 mmol/L |
| Category (ADA) | Diabetes range |
| Points from 5.7% prediabetes cut point | +7.6 |
| Points from 6.5% diabetes cut point | +6.8 |
| Points from 7.0% common treatment goal | +6.3 |
Extremely high A1C
An A1C of 13.3% corresponds to an estimated average glucose of about 335 mg/dL (18.6 mmol/L), 6.3 points above the 7% goal. This level reflects prolonged, marked hyperglycemia and needs prompt medical attention.
The ADAG study that produced the eAG equation enrolled people with A1C up to about 12%, so estimates above that are extrapolations. Very high values can occur with new-onset diabetes, stopped medication or illness, and are associated with dehydration and a risk of hyperglycemic crises such as diabetic ketoacidosis.
Practical next steps
- Seek medical care promptly.
- Check ketones if you have a meter or strips.
- Go to emergency care for vomiting, rapid breathing, confusion or severe weakness.
A1C values near 13.3%
Each 0.1 point of A1C equals about 2.9 mg/dL (0.16 mmol/L) of average glucose and about 1.1 mmol/mol on the IFCC scale.
| A1C | eAG mg/dL | eAG mmol/L | IFCC mmol/mol | Category |
|---|---|---|---|---|
| 12.3% | 306 | 17.0 | 111 | Diabetes range |
| 12.4% | 309 | 17.1 | 112 | Diabetes range |
| 12.5% | 312 | 17.3 | 113 | Diabetes range |
| 12.6% | 315 | 17.4 | 114 | Diabetes range |
| 12.7% | 318 | 17.6 | 115 | Diabetes range |
| 12.8% | 321 | 17.8 | 116 | Diabetes range |
| 12.9% | 324 | 17.9 | 117 | Diabetes range |
| 13.0% | 326 | 18.1 | 119 | Diabetes range |
| 13.1% | 329 | 18.2 | 120 | Diabetes range |
| 13.2% | 332 | 18.4 | 121 | Diabetes range |
| 13.3% | 335 | 18.6 | 122 | Diabetes range |
| 13.4% | 338 | 18.7 | 123 | Diabetes range |
| 13.5% | 341 | 18.9 | 124 | Diabetes range |
| 13.6% | 344 | 19.0 | 125 | Diabetes range |
| 13.7% | 346 | 19.2 | 126 | Diabetes range |
| 13.8% | 349 | 19.4 | 127 | Diabetes range |
| 13.9% | 352 | 19.5 | 128 | Diabetes range |
| 14.0% | 355 | 19.7 | 129 | Diabetes range |
How 13.3% compares with ADA goals
Goals differ by age, health and pregnancy. The ADA sets them individually; the figures below are the default goals in the Standards of Care.
| Group | Goal | This result |
|---|---|---|
| Most non-pregnant adults with diabetes | <7.0% | 6.3 points above |
| Healthy older adults (few chronic illnesses, intact cognition and function) | <7.5% | 5.8 points above |
| Older adults with complex or intermediate health | <8.0% | 5.3 points above |
| Children and adolescents with diabetes | <7.0% | 6.3 points above |
| Pregnancy with pre-existing diabetes | <6.0% | 7.3 points above |
Distance from 13.3% to lower targets
The change in average glucose needed to move from 13.3% to each goal, using the ADAG equation (28.7 mg/dL per A1C point).
| Target A1C | A1C drop | Average glucose drop | Average glucose at target |
|---|---|---|---|
| 8.0% | 5.3 points | 152 mg/dL | 183 mg/dL |
| 7.0% | 6.3 points | 181 mg/dL | 154 mg/dL |
| 6.5% | 6.8 points | 195 mg/dL | 140 mg/dL |
| 5.7% | 7.6 points | 218 mg/dL | 117 mg/dL |
Which weeks shaped this A1C
Hemoglobin glycation follows red blood cell turnover, so recent weeks count more. Kinetic modeling (Tahara and Shima, 1995) found that the most recent 30 days contribute about half of the A1C value. That is why a change in treatment shows up partially after one month and mostly after three.
| Period before the test | Share of A1C | Share of the 335 mg/dL average |
|---|---|---|
| Last 30 days | about 50% | 168 mg/dL weight |
| 30 to 60 days before | about 25% | 84 mg/dL weight |
| 60 to 120 days before | about 25% | 84 mg/dL weight |
When an A1C of 13.3% may not match your meter
- Iron-deficiency anemia can raise A1C; hemolysis, blood loss or a recent transfusion can lower it.
- Advanced chronic kidney disease, dialysis and erythropoietin therapy can lower it.
- Hemoglobin variants such as HbS, HbC or HbE can interfere with some assays; check that your lab method is NGSP-certified and variant-free.
- Late pregnancy lowers A1C because of faster red cell turnover.
Frequently asked questions
Is an A1C of 13.3% good?
An A1C of 13.3% is in the diabetes range (6.5% or higher). For people with diabetes it is 6.3 points above the common 7% goal.
What average blood sugar is an A1C of 13.3%?
Using the ADAG formula eAG = 28.7 × A1C − 46.7, an A1C of 13.3% equals about 335 mg/dL, or 18.6 mmol/L.
What is 13.3% A1C in mmol/mol?
With the IFCC master equation, (13.3 − 2.152) × 10.929 gives 122 mmol/mol.
Is 13.3% A1C diabetes?
Yes, 13.3% is at or above the 6.5% diagnostic threshold, but a diagnosis needs a second abnormal test unless there are clear symptoms with a random glucose of 200 mg/dL or more.
How long does it take to change an A1C of 13.3%?
Because the last 30 days carry about half the weight, a sustained change in average glucose begins to show after about 4 weeks, and most of it is reflected after 8 to 12 weeks. ADA suggests retesting about every 3 months after a treatment change.
Related pages
Sources
- Nathan DM, Kuenen J, Borg R, et al. Translating the A1C assay into estimated average glucose values (ADAG Study). Diabetes Care. 2008;31(8):1473-1478.
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 2: Diagnosis and Classification of Diabetes. Diabetes Care. 2026;49(Suppl 1).
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 6: Glycemic Goals and Hypoglycemia. Diabetes Care. 2026;49(Suppl 1).
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 13: Older Adults. Diabetes Care. 2026;49(Suppl 1).
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 14: Children and Adolescents. Diabetes Care. 2026;49(Suppl 1).
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 15: Management of Diabetes in Pregnancy. Diabetes Care. 2026;49(Suppl 1).
- Hoelzel W, Weykamp C, Jeppsson JO, et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes. Clin Chem. 2004;50(1):166-174. NGSP/IFCC master equation.
- Tahara Y, Shima K. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care. 1995;18(4):440-447.
- Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
- Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). BMJ. 2000;321(7258):405-412.
- National Glycohemoglobin Standardization Program (NGSP). Harmonizing hemoglobin A1c testing; factors that interfere with HbA1c test results.
This page is for education and does not replace advice from your doctor. Diagnosis of diabetes requires laboratory testing and, in most cases, a repeat test.